| PESAD22 | 'Delivery of clinical HIV prevention care and treatment services for Key Populations through safe spaces in Harare' | Poster exhibition | Young key populations |
| PESAD23 | Awareness and acceptability of undetectable=untransmittable among a national sample of HIV-negative young adults in Nigeria | Poster exhibition | Comprehensive sexuality education |
| PESAD24 | Differences in drug use and HIV stigma among people who inject drugs in Kyrgyzstan | Poster exhibition | People who inject drugs |
| PESAE01 | At risk in the emergency department: can the electronic health record identify patients with indications for PrEP? | Poster exhibition | Implementation science of scaling up prevention (including PrEP) |
| PESAE02 | The fidelity of a pharmacy-based PrEP delivery model in Kenya: an unannounced standardized patient actor assessment | Poster exhibition | Implementation science of scaling up prevention (including PrEP) |
| PESAE03 | Community preparedness to embrace new biomedical HIV prevention technologies. CHEDRA's experience with the Dapivirine vaginal ring and Female Sex Workers (FSWs) amidst a volatile atmosphere in Masaka, Uganda | Poster exhibition | Implementation science of scaling up prevention (including PrEP) |
| PESAE04 | Optimising provider-initiated indicator condition guided testing for HIV to identify undiagnosed individuals: preliminary results of a multifaceted, multicentre intervention study | Poster exhibition | Implementation science of scaling up HIV testing |
| PESAE05 | Index testing approaches for early diagnosis of PLHIV and treatment initiation for HIV epidemic control | Poster exhibition | Implementation science of scaling up HIV testing |
| PESAE07 | Long term effects of donor transition processes and their potential influence on the realization of the country's 90-90-90 targets. Experiences from a subnational level in Uganda | Poster exhibition | Implementation science of scaling up HIV treatment |
| PESAE08 | High rates of interruptions in HIV treatment in people living with HIV on ART less than three months across the age continuum | Poster exhibition | Implementation science of scaling up HIV treatment |